Adenovirus Based Virotherapy Market - Regional Analysis
|
Type |
|
|
End User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of adenovirus based virotherapy is estimated at USD 15.26 billion.
The global adenovirus based virotherapy market size was around USD 14.5 billion in 2025 and is likely to expand at a CAGR of more than 5.8%, surpassing USD 25.48 billion revenue by 2035.
Key players in the market include Amgen Inc., Merck & Co., Inc., Novartis International AG, Johnson & Johnson, Genelux Corporation, PsiOxus Therapeutics, Oncorus, Inc.
